Company Overview of Capricor, Inc.
Capricor, Inc., a biotechnology company, develops and commercializes cardiac stem cell treatments to regenerate the heart. Its products include intracoronary cardiosphere-derived cells for the treatment of myocardial infarction; intramyocardial cardiospheres for heart failure patients with low-ejection fraction. The company was founded in 2005 and is headquartered in Los Angeles, California.
8700 Beverly Boulevard
Los Angeles, CA 90048
Founded in 2005
Key Executives for Capricor, Inc.
Capricor, Inc. Key Developments
Similar Private Companies By Industry
|BioLogics, Inc.||United States|
|GlaxoSmithKline Capital, Inc.||United States|
|Comsort, Inc.||United States|
|Plasmonix, Inc.||United States|
|Outlook Pharmaceuticals Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Post a JobJobs
- Milwaukee, WI | Robert W. BairdPosted: Apr 19
- Cambridge, MA | ElsevierPosted: May 23
- San Francisco, CA | Confidential Biotechnology CompanyPosted: May 13
- New Haven, CT | FlextonPosted: Apr 04
Sponsored Financial Commentaries
To contact Capricor, Inc., please visit www.capricor.com. Company data is provided by Capital IQ. Please use this form to report any data issues.